ETV6 and Thrombocytopenia: Collectively, these data suggest that ETV6 is required for homeostatic transcriptional control in MKs, and the altered interferon and cytoskeletal gene programs we observed may predispose patients with ETV6 mutations to thrombocytopenia via decreased proplatelet formation.